Fortitech Deal Fills Gap In DSM’s Nutritional Portfolio
This article was originally published in The Tan Sheet
Executive Summary
DSM’s announcement of its $634 million cash acquisition of Fortitech follows the firm’s report that its nutritional business was the key sales driver in its latest earnings period. Fortitech adds macro-blend manufacturing for human nutritional products to DSM’s supply chain.